BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23840453)

  • 1. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium.
    Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C
    PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumourigenicity of iPS cells and their differentiated derivates.
    Liu Z; Tang Y; Lü S; Zhou J; Du Z; Duan C; Li Z; Wang C
    J Cell Mol Med; 2013 Jun; 17(6):782-91. PubMed ID: 23711115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients.
    Lepperhof V; Polchynski O; Kruttwig K; Brüggemann C; Neef K; Drey F; Zheng Y; Ackermann JP; Choi YH; Wunderlich TF; Hoehn M; Hescheler J; Sarić T
    PLoS One; 2014; 9(9):e107363. PubMed ID: 25226590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
    Adamiak M; Cheng G; Bobis-Wozowicz S; Zhao L; Kedracka-Krok S; Samanta A; Karnas E; Xuan YT; Skupien-Rabian B; Chen X; Jankowska U; Girgis M; Sekula M; Davani A; Lasota S; Vincent RJ; Sarna M; Newell KL; Wang OL; Dudley N; Madeja Z; Dawn B; Zuba-Surma EK
    Circ Res; 2018 Jan; 122(2):296-309. PubMed ID: 29118058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
    Rojas SV; Kensah G; Rotaermel A; Baraki H; Kutschka I; Zweigerdt R; Martin U; Haverich A; Gruh I; Martens A
    PLoS One; 2017; 12(5):e0173222. PubMed ID: 28493867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes.
    Funakoshi S; Miki K; Takaki T; Okubo C; Hatani T; Chonabayashi K; Nishikawa M; Takei I; Oishi A; Narita M; Hoshijima M; Kimura T; Yamanaka S; Yoshida Y
    Sci Rep; 2016 Jan; 6():19111. PubMed ID: 26743035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction.
    Ong SG; Huber BC; Lee WH; Kodo K; Ebert AD; Ma Y; Nguyen PK; Diecke S; Chen WY; Wu JC
    Circulation; 2015 Aug; 132(8):762-771. PubMed ID: 26304668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.
    Swijnenburg RJ; Tanaka M; Vogel H; Baker J; Kofidis T; Gunawan F; Lebl DR; Caffarelli AD; de Bruin JL; Fedoseyeva EV; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I166-72. PubMed ID: 16159810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.
    Neyrinck K; Breuls N; Holvoet B; Oosterlinck W; Wolfs E; Vanbilloen H; Gheysens O; Duelen R; Gsell W; Lambrichts I; Himmelreich U; Verfaillie CM; Sampaolesi M; Deroose CM
    Theranostics; 2018; 8(10):2799-2813. PubMed ID: 29774076
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of induced pluripotent stem cells.
    Zhao T; Zhang ZN; Rong Z; Xu Y
    Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
    Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
    Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice.
    Kashiyama N; Miyagawa S; Fukushima S; Kawamura T; Kawamura A; Yoshida S; Harada A; Watabe T; Kanai Y; Toda K; Hatazawa J; Sawa Y
    PLoS One; 2016; 11(12):e0165748. PubMed ID: 27930666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
    Tachibana A; Santoso MR; Mahmoudi M; Shukla P; Wang L; Bennett M; Goldstone AB; Wang M; Fukushi M; Ebert AD; Woo YJ; Rulifson E; Yang PC
    Circ Res; 2017 Sep; 121(6):e22-e36. PubMed ID: 28743804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
    Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
    Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.
    Kim EM; Manzar G; Zavazava N
    Immunology; 2017 Jun; 151(2):191-197. PubMed ID: 28185259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation.
    Swijnenburg RJ; Schrepfer S; Cao F; Pearl JI; Xie X; Connolly AJ; Robbins RC; Wu JC
    Stem Cells Dev; 2008 Dec; 17(6):1023-9. PubMed ID: 18491958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
    Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
    Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal Imaging for In Vivo Evaluation of Induced Pluripotent Stem Cells in a Murine Model of Heart Failure.
    Rojas SV; Meier M; Zweigerdt R; Eckardt D; Rathert C; Schecker N; Schmitto JD; Rojas-Hernandez S; Martin U; Kutschka I; Haverich A; Martens A
    Artif Organs; 2017 Feb; 41(2):192-199. PubMed ID: 27296083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.